Page last updated: 2024-09-03

gefitinib and Adenoma, Oxyphilic

gefitinib has been researched along with Adenoma, Oxyphilic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clark, JR; Daniels, GH; Evans, T; Fidias, PH; Gurubhagavatula, S; Haddad, RI; Heist, RS; Lynch, TJ; Pennell, NA; Ross, DS; Temel, JS; Wirth, LJ	1

Trials

1 trial(s) available for gefitinib and Adenoma, Oxyphilic

Article	Year
A phase II study of gefitinib in patients with advanced thyroid cancer. Thyroid : official journal of the American Thyroid Association, 2008, Volume: 18, Issue:3 Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Aged; Antineoplastic Agents; Carcinoma, Medullary; Carcinoma, Papillary; Female; Gefitinib; Humans; Kaplan-Meier Estimate; Male; Quinazolines; Severity of Illness Index; Thyroglobulin; Thyroid Neoplasms; Treatment Outcome	2008

Article

Year

A phase II study of gefitinib in patients with advanced thyroid cancer.

Thyroid : official journal of the American Thyroid Association, 2008, Volume: 18, Issue:3

Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Aged; Antineoplastic Agents; Carcinoma, Medullary; Carcinoma, Papillary; Female; Gefitinib; Humans; Kaplan-Meier Estimate; Male; Quinazolines; Severity of Illness Index; Thyroglobulin; Thyroid Neoplasms; Treatment Outcome

2008